If you're into sci-fi flicks, then this new FDA approval will grab your attention.
Soon, thousands of genetically modified Aedes aegypti mosquitoes will be released in the Florida Keys. Biotech company Oxitec designed these disease-obliterating mosquitos to wipe out large mosquito populations.
These mutant mozzies carry the Zika virus and are bred to pass on a fatal gene to any offspring they have with wild female mosquitos. Over time, this breeding will result in the killing of most of the local mosquitos.
Oxitec says they have performed similar trials in Brazil, Panama and the Caymen Islands with a 90 percent reduction of the overall mosquito population.
The FDA finished their review and has found no significant impact of the release of our mosquito on human health or the environment.
However, this new technology has some folks shaking their heads. Killing off large populations of bugs can have potential environmental impacts. Naysayers also point out the absence of data that supports the efficiency of such tactics against disease.
But this hasn't stopped the FDA from giving their blessing to the trial.